These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19210158)

  • 1. Cardiovascular disease in patients with renal disease: the role of statins.
    Fellström B; Holdaas H; Jardine AG; Svensson MK; Gottlow M; Schmieder RE; Zannad F;
    Curr Med Res Opin; 2009 Jan; 25(1):271-85. PubMed ID: 19210158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials.
    Chan DT; Irish AB; Dogra GK; Watts GF
    Atherosclerosis; 2008 Feb; 196(2):823-34. PubMed ID: 17343861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of statins in chronic kidney disease.
    Kalaitzidis RG; Elisaf MS
    Am J Nephrol; 2011; 34(3):195-202. PubMed ID: 21791915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007784. PubMed ID: 19370693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins on renal function.
    Agarwal R
    Mayo Clin Proc; 2007 Nov; 82(11):1381-90. PubMed ID: 17976359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
    Kanbay M; Turgut F; Covic A; Goldsmith D
    J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
    Scarpioni R; Ricardi M; Melfa L; Cristinelli L
    Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and statins: improving cardiovascular outcomes.
    Walker DB; Walker TJ; Jacobson TA
    Curr Atheroscler Rep; 2009 Jul; 11(4):301-8. PubMed ID: 19500494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era.
    Heymann EP; Kassimatis TI; Goldsmith DJ
    J Nephrol; 2012; 25(4):460-72. PubMed ID: 22641572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia in patients with chronic kidney disease.
    Hager MR; Narla AD; Tannock LR
    Rev Endocr Metab Disord; 2017 Mar; 18(1):29-40. PubMed ID: 28000009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based statin prescription for cardiovascular protection in renal impairment.
    Fabbian F; De Giorgi A; Pala M; Tiseo R; Manfredini R; Portaluppi F
    Clin Exp Nephrol; 2011 Aug; 15(4):456-63. PubMed ID: 21556807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia in children with CKD: should we treat with statins?
    Tullus K
    Pediatr Nephrol; 2012 Mar; 27(3):357-62. PubMed ID: 21487766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonstatin therapies for management of dyslipidemia: a review.
    Sando KR; Knight M
    Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
    Hou W; Lv J; Perkovic V; Yang L; Zhao N; Jardine MJ; Cass A; Zhang H; Wang H
    Eur Heart J; 2013 Jun; 34(24):1807-17. PubMed ID: 23470492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is lipid management effective for all stages of CKD?
    Ku E; Campese V
    Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The interest of statins in nephrology].
    Massy ZA; Andréjak M
    Presse Med; 2004 Oct; 33(17):1207-12. PubMed ID: 15523292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
    Rysz J; Gluba-Brzózka A; Banach M; Więcek A
    Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
    Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
    Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.
    Kasiske B; Cosio FG; Beto J; Bolton K; Chavers BM; Grimm R; Levin A; Masri B; Parekh R; Wanner C; Wheeler DC; Wilson PW;
    Am J Transplant; 2004; 4 Suppl 7():13-53. PubMed ID: 15027968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.